A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Public ClinicalTrials.gov record NCT00793819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Phase 2 Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Silodosin is compared to placebo to determine if it is safe and effective for the treatment of nighttime urination (nocturia) in men with BPH
Study identification
- NCT ID
- NCT00793819
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 215 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2009 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Mar 9, 2012
2009
United States locations
- U.S. sites
- 27
- U.S. states
- 20
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site | Huntsville | Alabama | — | — |
| Watson Investigational Site | Laguna Hills | California | — | — |
| Watson Investigational Site | San Diego | California | — | — |
| Watson Investigational Site | Aventura | Florida | — | — |
| Watson Investigational Site | Clearwater | Florida | — | — |
| Watson Investigational Site | Orlando | Florida | — | — |
| Watson Investigational Site | Marietta | Georgia | — | — |
| Watson Investigational Site | Sandy Springs | Georgia | — | — |
| Watson Investigational Site | Coeur d'Alene | Idaho | — | — |
| Watson Investigational Site | West Des Moines | Iowa | — | — |
| Watson Investigational Site | Paducah | Kentucky | — | — |
| Watson Investigational Site | Greenbelt | Maryland | — | — |
| Watson Investigational Site | Troy | Michigan | — | — |
| Watson Investigational Site | Missoula | Montana | — | — |
| Watson Investigational Site | Omaha | Nebraska | — | — |
| Watson Investigational Site | Las Vegas | Nevada | — | — |
| Watson Investigational Site | Lawrenceville | New Jersey | — | — |
| Watson Investigational Site | Albuquerque | New Mexico | — | — |
| Watson Investigational Site | Bay Shore | New York | — | — |
| Watson Investigational Site | New York | New York | — | — |
| Watson Investigational Site | Williamsville | New York | — | — |
| Watson Investigational Site | Concord | North Carolina | — | — |
| Watson Investigational Site | Salisbury | North Carolina | — | — |
| Watson Investigational Site | Bethany | Oklahoma | — | — |
| Watson Investigational Site | Bala-Cynwyd | Pennsylvania | — | — |
| Watson Investigational Site | Myrtle Beach | South Carolina | — | — |
| Watson Investigational Site | Burien | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00793819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2012 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00793819 live on ClinicalTrials.gov.